CD5E 📈 Amundi Index Solutions - - Overview
Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: LU1681047319 • Eurozone Large-Cap Equity
CD5E: Stocks, Bonds, ETFs, Index Funds
The investment seeks to track the performance of EURO STOXX 50 Index, and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index ‣ Company URL: https://first-eagle.amundi.com/ ‣ Domicile: Luxembourg ‣ Index Name: Morningstar Dev Ezn TME NR EUR
Additional Sources for CD5E ETF
CD5E ETF Overview
| Market Cap in USD | 667m |
| Category | Eurozone Large-Cap Equity |
| TER | 0.09% |
| IPO / Inception | 2018-02-14 |
CD5E ETF Ratings
| Growth 5y | 72.3% |
| Fundamental | - |
| Dividend | 5.50% |
| Rel. Strength Industry | 168 |
| Analysts | - |
| Fair Price Momentum | 77.19 EUR |
| Fair Price DCF | - |
CD5E Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 100.0% |
CD5E Growth Ratios
| Growth Correlation 3m | -0.3% |
| Growth Correlation 12m | 87.7% |
| Growth Correlation 5y | 87.7% |
| CAGR 5y | 38.99% |
| CAGR/Mean DD 5y | 5.63 |
| Sharpe Ratio 12m | 0.87 |
| Alpha | 30.45 |
| Beta | 0.19 |
| Volatility | 17.06% |
| Current Volume | 0k |
| Average Volume 20d | 1.9k |
What is the price of CD5E stocks?
As of December 22, 2024, the stock is trading at EUR 76.94 with a total of 0 shares traded.
Over the past week, the price has changed by -0.32%, over one month by +5.68%, over three months by -1.17% and over the past year by +13.67%.
As of December 22, 2024, the stock is trading at EUR 76.94 with a total of 0 shares traded.
Over the past week, the price has changed by -0.32%, over one month by +5.68%, over three months by -1.17% and over the past year by +13.67%.
Is Amundi Index Solutions - a good stock to buy?
Yes. Based on ValueRay Analyses, Amundi Index Solutions - (SW:CD5E) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 72.29 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CD5E as of December 2024 is 77.19. This means that CD5E is currently overvalued and has a potential downside of 0.32%.
Yes. Based on ValueRay Analyses, Amundi Index Solutions - (SW:CD5E) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 72.29 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CD5E as of December 2024 is 77.19. This means that CD5E is currently overvalued and has a potential downside of 0.32%.
Is CD5E a buy, sell or hold?
Amundi Index Solutions - has no consensus analysts rating.
Amundi Index Solutions - has no consensus analysts rating.
What are the forecast for CD5E stock price target?
According to ValueRays Forecast Model, CD5E Amundi Index Solutions - will be worth about 83.6 in December 2025. The stock is currently trading at 76.94. This means that the stock has a potential upside of +8.71%.
According to ValueRays Forecast Model, CD5E Amundi Index Solutions - will be worth about 83.6 in December 2025. The stock is currently trading at 76.94. This means that the stock has a potential upside of +8.71%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 83.6 | 8.7% |